NAPISTAR 1-01: An international phase I/II trial of the novel ADC TUB-040 in platinum-resistant ovarian cancer (PROC) and relapsed/refractory adenocarcinoma non-small cell lung cancer (NSCLC).

Authors: Toon Van Gorp, Antonio Gonzalez Martin, Shiraj Sen, Jalid Sehouli, Alex Spira, Valentina Boni, Rebecca Kristeleit, Debra L. Richardson, James F. Spicer, Juergen Wolf, Heather Scharpenseel, Lea Ruge, Frederik Herzberg, Ignacio Matos, Günter Fingerle-Rowson, Ines Isabel Monteiro Vasconcelos, Sebastian Ochsenreither, Alexander Starodub

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps8660

Source: Full article

---

Abstract

TPS8660